Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Three Anti-Pneumocystis Agents Plus Zidovudine for PCP Prevention in Advanced HIV
NCT00000991Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole, dapsone, pentamidine in Pneumocystis jirovecii pneumonia (PJP), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
trimethoprim + sulfamethoxazoledapsonepentamidine
03
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT00000991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000991.